| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.03▼ | 1.05▼ | 1.05▼ | 1.07▼ | 1.10▼ |
| MA10 | 1.05▼ | 1.05▼ | 1.05▼ | 1.08▼ | 1.47▼ |
| MA20 | 1.04▼ | 1.04▼ | 1.05▼ | 1.14▼ | 1.28▼ |
| MA50 | 1.05▼ | 1.06▼ | 1.07▼ | 1.53▼ | 0.87▲ |
| MA100 | 1.06▼ | 1.13▼ | 1.14▼ | 1.23▼ | 1.86▼ |
| MA200 | 1.14▼ | 1.15▼ | 1.19▼ | 0.91▲ | 13.91▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.002▼ | 0.001▲ | 0.001▲ | 0.013▲ | -0.087▼ |
| RSI | 43.559▼ | 44.097▼ | 43.431▼ | 40.134▼ | 47.810▼ |
| STOCH | 25.463 | 52.778 | 52.778 | 41.682 | 8.253▼ |
| WILL %R | -83.333▼ | -83.333▼ | -83.333▼ | -84.848▼ | -87.398▼ |
| CCI | -69.307 | -41.102 | -49.448 | -84.632 | -59.550 |
|
Tuesday, October 21, 2025 12:07 AM
NovaBay Pharmaceuticals (NYSE:NBY) has formally regained compliance with the NYSE American's continued listing standards, successfully resolving deficiencies first cited in April and May 2024. The ...
|
|
Monday, October 20, 2025 05:07 PM
EMERYVILLE, Calif., Oct. 20, 2025 (GLOBE NEWSWIRE) -- NovaBay Pharmaceuticals, Inc. (NBY) (NYSE American: NBY) ("NovaBay" or the "Company") announces that it has regained compliance with the NYSE ...
|
|
Sunday, October 19, 2025 04:22 AM
NovaBay Pharmaceuticals, Inc. engages in the development and sales of scientifically-created and clinically-proven eyecare and skincare. Its products include Avenova, NeutroPhase and DERMAdoctor. The ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 14/11/25 | 1.05 | 1.09 | 1.01 | 1.03 | 74,200 |
| 13/11/25 | 1.03 | 1.10 | 1.00 | 1.10 | 256,000 |
| 12/11/25 | 1.07 | 1.11 | 1.05 | 1.08 | 143,600 |
| 11/11/25 | 1.07 | 1.09 | 1.03 | 1.07 | 199,400 |
| 10/11/25 | 1.08 | 1.09 | 1.00 | 1.08 | 84,500 |
| 07/11/25 | 1.08 | 1.08 | 0.98 | 1.06 | 163,600 |
| 06/11/25 | 1.10 | 1.10 | 1.06 | 1.07 | 63,000 |
| 05/11/25 | 1.10 | 1.11 | 1.08 | 1.11 | 115,900 |
| 04/11/25 | 1.08 | 1.14 | 1.07 | 1.10 | 117,200 |
| 03/11/25 | 1.13 | 1.14 | 1.09 | 1.09 | 145,900 |
|
|
||||
|
|
||||
|
|